$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Current status of generic tazerestat and patient purchasing guide
2026-02-01 22:25:32
Check Details
Tazetostat is an effective treatment option for specific cancers
2026-02-01 22:25:32
Check Details
Tazetostat: A new breakthrough in cancer treatment with EZH2 enzyme inhibitors
2026-02-01 22:25:32
Check Details
Adverse reactions and coping strategies during tazetostat treatment
2026-02-01 22:25:32
Check Details
Detailed explanation of correct dosage guidelines and dosage adjustment of tazetostat
2026-02-01 22:25:32
Check Details
Tazerestat inhibits EZH2 enzyme
2026-02-01 22:25:32
Check Details
Discussion on the accessibility of mitotane in the country
2026-02-01 22:25:32
Check Details
An introduction to mitotane and an overview of its market price
2026-02-01 22:25:32
Check Details
Analysis of Domestic Availability of Mitotane Drugs
2026-02-01 22:25:32
Check Details
Discussion on the accessibility of mitotane in the country
2026-02-01 22:25:32
Check Details
Medication Guide for Mitotane in the Treatment of Adrenocortical Cancer
2026-02-01 22:25:32
Check Details
Do I need to take mitotane for life?
2026-02-01 22:25:32
Check Details
1
2
...
1000
1001
1002
1003
1004
1005
1006
...
10223
10224
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Eltrombopag Administration Timing and Alternative Therapy Guide
2
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
3
Avatrombopag: A Complete Guide to Dosage, Mechanism, and Clinical Use
4
Tazemetostat Dosage Guide: Laos Generic vs. Original Tazverik Comparison
5
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
6
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
7
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
8
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
9
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison
10
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
11
Elagolix Side Effects and Safety Guide
12
Hetrombopag vs. Avatrombopag: Key Differences Between Two Oral TPO-RAs and Safety Considerations